E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/9/2019 in the Prospect News Structured Products Daily.

New Issue: Credit Suisse prices $855,000 contingent coupon autocallables linked to biotech, oil ETFs

By Wendy Van Sickle

Columbus, Ohio, April 9 – Credit Suisse AG, London Branch priced $855,000 of contingent coupon autocallable yield notes due April 5, 2021 linked to the lesser performing of the SPDR S&P Biotech exchange-traded fund and the SPDR S&P Oil & Gas Exploration & Production exchange-traded fund, according to a 424B2 filing with the Securities and Exchange Commission.

Each quarter, the notes pay a contingent coupon at the rate of 13.5% per year if each ETF closes at or above its knock-in level, 60% of its initial share price, on the observation date for that quarter.

Beginning Sept. 30, the notes will be automatically called at par if each ETF closes at or above its initial share price on any quarterly observation date.

The payout at maturity will be par unless either ETF closes below its knock-in level during the life of the notes, in which case the payout will be par plus the return of the lesser-performing ETF, subject to a maximum payout of par.

Credit Suisse Securities (USA) LLC and Incapital LLC are the agents.

Issuer:Credit Suisse AG, London Branch
Issue:Contingent coupon autocallable yield notes
Underlying ETFs:SPDR S&P Biotech ETF and SPDR S&P Oil & Gas Exploration & Production ETF
Amount:$855,000
Maturity:April 5, 2021
Coupon:Each quarter, notes pay contingent coupon at rate of 13.5% per year unless either ETF closes below knock-in level on observation date for that quarter
Price:Par
Payout at maturity:Par unless either ETF closes below knock-in level during life of notes, in which case par plus return of lesser-performing ETF, subject to maximum payout of par
Call:Beginning Sept. 30, automatically at par if each ETF closes at or above initial share price on any quarterly observation date
Initial share prices:$90.54 for biotech ETF and $30.74 for oil ETF
Knock-in levels:$54.324 for biotech ETF and $18.444 for oil ETF; 60% of initial share prices
Pricing date:March 29
Settlement date:April 3
Agents:Credit Suisse Securities (USA) LLC and Incapital LLC
Fees:0.75%
Cusip:22551LYQ7

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.